Virus-Like Particles (VLPs) have emerged as indispensable tools. They can be utilized for applications in vaccine research, diagnostics, and therapeutic development. The partnership between The Native Antigen Company, known for high-purity and high-quality VLP production, and PUXANO, known for world-class structural biology services, has resulted in an innovative case study on the structural elucidation of Chikungunya Virus-Like Particles.
Read our latest white paper and delve into this collaborative effort, showcasing the unparalleled potential of combining expertise to advance research programs with valuable structural insights.
